SEC Form 4 · accession 0001645627-18-000004
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jan 11, 2018
Accepted (ET)
Jan 23, 2018 · 12:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 11, 2018 | P | 2,000 | $0.0565 | A | 24,719,189 | D | |
| Common Stock | Jan 11, 2018 | P | 1,000 | $0.057 | A | 24,720,189 | D | |
| Common Stock | Jan 16, 2018 | P | 3,000 | $0.0534 | A | 24,723,189 | D | |
| Common Stock | Jan 16, 2018 | P | 3,000 | $0.056 | A | 24,726,189 | D | |
| Common Stock | Jan 16, 2018 | P | 3,000 | $0.0548 | A | 24,729,189 | D | |
| Common Stock | Jan 17, 2018 | P | 3,000 | $0.0529 | A | 24,732,189 | D | |
| Common Stock | Jan 18, 2018 | P | 1,000 | $0.0535 | A | 24,733,189 | D | |
| Common Stock | Jan 18, 2018 | P | 2,000 | $0.054 | A | 24,735,189 | D | |
| Common Stock | Jan 18, 2018 | P | 1,000 | $0.0537 | A | 24,736,189 | D | |
| Common Stock | Jan 18, 2018 | P | 2,000 | $0.0551 | A | 24,738,189 | D | |
| Common Stock | Jan 18, 2018 | P | 2,000 | $0.057 | A | 24,740,189 | D |
Table II — derivative securities
No Table II lines on this filing.